JENNIFER BECKER: Open Payments
NPI 1649577115 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,511 in 121 payments from 28 companies in 2025. Trend: 2023 $2,211 · 2024 $4,610 · 2025 $2,511
Food & beverage: $2,511
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $328 |
| Insulet Corporation | 21 | $292 |
| Dexcom, Inc. | 10 | $240 |
| Xeris Pharmaceuticals, Inc. | 9 | $187 |
| Novo Nordisk Inc | 11 | $149 |
| Medtronic, Inc. | 8 | $138 |
| Sequel Med Tech, LLC | 5 | $115 |
| Ascendis Pharma Endocrinology Inc | 5 | $106 |
| SANOFI-AVENTIS U.S. LLC | 4 | $100 |
| Abbott Laboratories | 4 | $95 |
Products named: Omnipod, Dexcom G6 Transmitter, GVOKE HYPOPEN, REPATHA, TEPEZZA, MINIMED 780G, TWIIST, Yorvipath.
Industry payments across FL — which companies pay providers there.
